Showing results (21-30 of 133) with videos related to

Sort By:
Pageof 14
The Journal of Rheumatology. Supplement|November 3, 2011
Quality of life issues in pediatric immune-mediated inflammatory diseaseCiarán M Duffy, George A Wells, Anthony S Russell, et al.
Rheumatology and Therapy|October 30, 2018
Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional StudyBoulos Haraoui, Shahin Jamal, Vandana Ahluwalia, et al.
The Journal of Rheumatology|April 3, 2012
Treating rheumatoid arthritis to target: a Canadian physician surveyBoulos Haraoui, William Bensen, Louis Bessette, et al.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry|January 5, 2013
Biologics and the cardiovascular system: a double-edged swordCamille Roubille, Johanne Martel-Pelletier, Boulos Haraoui, et al.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry|January 5, 2013
Cardiovascular adverse effects of anti-inflammatory drugsCamille Roubille, Johanne Martel-Pelletier, Jean-Marc Davy, et al.
The Journal of Rheumatology. Supplement|November 3, 2011
Validity of quality of life measurement tools--from generic to disease-specificGeorge A Wells, Anthony S Russell, Boulos Haraoui, et al.
Arthritis Research & Therapy|September 27, 2023
Effectiveness of a treat-to-target strategy in patients with moderate to severely active rheumatoid arthritis treated with abataceptLouis Bessette, Boulos Haraoui, Emmanouil Rampakakis, et al.
The Journal of Rheumatology|October 17, 2007
Advantages and limitations of utility assessment methods in rheumatoid arthritisAriel Beresniak, Anthony S Russell, Boulos Haraoui, et al.
Pageof 14